Reaktion #2186208
ord-7e3aa44568994649a2ef2db65678e6ec
Reaktionsgleichung
sodium bicarbonate
3-Benzothiazol-2-yl-7-[4-(3-hydroxy-propyl)-piperazin-1-yl]-chromen-2-one
Hünig base
tosyl chloride
→
Toluene-4-sulfonic acid 3-[4-(3-benzothiazol-2-yl-2-oxo-2H-chromen-7-yl)-piperazin-1-yl]-propyl ester
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Detaillierte Bedingungen
See reaction.notes.procedure_details.
Aufarbeitung
- 1workup.ADDITIONpoured onto ice
- 2Extraktionextracted (dichloromethane, saline)
- 3SonstigeThe organic phase is evaporated
- 4Sonstigethe residue column chromatographed (silica gel, dichloromethane/EtOH 98:2)
- 5Sonstigeto yield
- 6Sonstigeafter evaporation
- 7Trocknendrying under high vacuum 73 mg (78%) desired product as a light brownish powder
Vorschrift
70 mg (0.16 mmol) 3-Benzothiazol-2-yl-7-[4-(3-hydroxy-propyl)-piperazin-1-yl]-chromen-2-one are dissolved in 15 mL dichloromethane under argon. 0.083 mL Hünig base and 10 mg DMAP are added to the stirred solution, followed by 46 mg (1.5 eq.) tosyl chloride. The reaction mixture is stirred for 20 h at room temperature, poured onto ice, treated with 2 mL aqueous sodium bicarbonate solution and extracted (dichloromethane, saline). The organic phase is evaporated and the residue column chromatographed (silica gel, dichloromethane/EtOH 98:2) to yield after evaporation and drying under high vacuum 73 mg (78%) desired product as a light brownish powder.